viral infection

Empirical Data Shows mRNA Flu Vaccine Offers Enhanced, Sustained Immunity

Moderna's mRNA flu vaccine, mFlusiva, outperforms standard shots by generating stronger, longer-lasting immunity and better preventing infection, according to empirical data. The findings underscore a measurable advance in vaccine science, one built on validated, real-world performance rather than promise. This is what integrated, peer-reviewed progress looks like. For more on how data systems track environmental shifts, our related piece, "Integrated Subsea Cables Enhance Data Transmission Across the Indian Ocean," offers a broader view of connectivity's role in ocean intelligence.